Multiple sclerosis and Castleman's disease

Summary:

Castleman's disease is found among people with Multiple sclerosis, especially for people who are female, 20-29 old.

The study analyzes which people have Castleman's disease with Multiple sclerosis. It is created by eHealthMe based on reports of 15 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,088 drugs and 1,359 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.

What is Castleman's disease?

Castleman's disease (a disease of lymph nodes and related tissues) is found to be associated with 49 drugs and 116 conditions by eHealthMe. Check the latest studies of Castleman's disease.

On Jul, 18, 2026

15 people who have Multiple Sclerosis and Castleman'S Disease are studied.

Would you have Castleman's disease when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experienced Castleman'S Disease *:

female: 66.67 %
male: 33.33 %

Age of people who have Multiple Sclerosis and experienced Castleman'S Disease *:

Common co-existing conditions for these people *:

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 33.33%
Asthma: 5 people, 33.33%
Respiratory Distress (difficulty in breathing): 4 people, 26.67%
Pain: 4 people, 26.67%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 3 people, 20.00%
Musculoskeletal Disorder (disease of the body's muscles, joints, tendons, ligaments and nerves): 1 person, 6.67%
Gait Disturbance: 1 person, 6.67%
Fatigue (feeling of tiredness): 1 person, 6.67%

Common drugs taken by these people *:

Common symptoms for these people *:

Adrenal Insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids): 5 people, 33.33%
Cardiac Arrest: 4 people, 26.67%
Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 26.67%
Renal Tubular Necrosis (death of kidney tubules): 4 people, 26.67%
Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 4 people, 26.67%
Colitis Ischaemic (due to infection of intestine impaired blood supply to colon): 4 people, 26.67%
Dehydration (dryness resulting from the removal of water): 4 people, 26.67%
Post Procedural Fistula: 3 people, 20.00%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 2 people, 13.33%
Feeling Abnormal: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Castleman's disease?

- Check whether Castleman's disease is associated with a drug or a condition

Related publications that referenced our studies

Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Castleman's disease and Multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.